CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $158,000 | – | 8,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 715,351 | $11,617,000 | 0.23% |
| ARK Investment Management | 411,880 | $6,689,000 | 0.17% |
| Nikko Asset Management Americas, Inc. | 532,825 | $8,653,000 | 0.14% |
| HHLR ADVISORS, LTD. | 235,214 | $3,820,000 | 0.05% |
| Vident Investment Advisory, LLC | 17,479 | $284,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 532,825 | $8,653,000 | 0.01% |
| MEEDER ASSET MANAGEMENT INC | 3,195 | $52,000 | 0.00% |
| Russell Investments Group, Ltd. | 67,474 | $1,094,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 312,782 | $5,078,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $303,000 | 0.00% |